agilon health, inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Timothy O'Rourke (CEO) and Jeffrey Schwaneke (CFO) certified on November 4, 2026 that the Q3 2026 10-Q for period ended September 30, 2026 complies with SEC requirements, financial statements fairly present the company's condition and results, and disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud disclosures were noted.
Why this rating
Routine SOX certification exhibits; standard quarterly compliance filing with no disclosed control deficiencies, fraud, or operational changes disclosed.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.